Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12060349 Glucosylceramide synthase inhibitors

Patent 12060349 was granted and assigned to Genzyme on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Cassandra Celatka0

Katherine Jancsics0

Oxana Beskrovnaya0

Renato Skerlj0

Zhong Zhao0

Ronald K. Scheule0

Seng H. Cheng0

Markus Metz0

...

Date of Patent

August 13, 2024

0

Patent Application Number

172303850

Date Filed

April 14, 2021

0

Patent Citations

US Patent 7138410 Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor

0

US Patent 7273872 Inhibition of inflammation using α 7 receptor-binding cholinergic agonists

0

US Patent 7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors

0

US Patent 6916828 Carbamates derivatived from arylakylamines

0

US Patent 6953855 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof

0

US Patent 6987106 1,4-diazabicyclo[3.2.2]nonane-4-carboxylates and carboxamide derivates, production and use thereof in therapeutics

0

US Patent 7091227 Benzothiazole derivatives

0

US Patent 7115629 Carbamates derived from arylalkylamines

0

...

Patent Primary Examiner

Brian E McDowell

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12060349 Glucosylceramide synthase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.